Matches in Wikidata for { <http://www.wikidata.org/entity/Q63811530> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q63811530 description "clinical trial" @default.
- Q63811530 description "ensayu clínicu" @default.
- Q63811530 description "klinisch onderzoek" @default.
- Q63811530 description "клінічне випробування" @default.
- Q63811530 name "The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia" @default.
- Q63811530 type Item @default.
- Q63811530 label "The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia" @default.
- Q63811530 prefLabel "The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia" @default.
- Q63811530 P1050 Q63811530-5553B150-C019-4E6F-9632-365286343456 @default.
- Q63811530 P1132 Q63811530-A457F405-B3FF-4A47-B7D6-06F05217A26C @default.
- Q63811530 P1476 Q63811530-01895682-B50F-453F-92AC-1B9A1DBC4CAD @default.
- Q63811530 P2899 Q63811530-617101F3-AF77-4F17-B08D-5EC7624D76B8 @default.
- Q63811530 P3098 Q63811530-15CBBAB5-BF5B-47B1-80C9-966215DA2B4C @default.
- Q63811530 P31 Q63811530-66D79574-E192-45D2-BB55-0BC3B9F6BEC8 @default.
- Q63811530 P4844 Q63811530-9CB547AE-35C0-4D3C-8C50-9708AC292566 @default.
- Q63811530 P4844 Q63811530-CA285071-C629-4636-B849-F8888475F7B0 @default.
- Q63811530 P580 Q63811530-9725324B-EAA6-48AE-979A-EF56015FC809 @default.
- Q63811530 P582 Q63811530-48C39B99-778E-44A0-B9D2-BE9830BF67B2 @default.
- Q63811530 P6099 Q63811530-4D8A3073-235A-4B5F-9F90-77117833A148 @default.
- Q63811530 P6153 Q63811530-BCABBA70-7DD7-42D9-82D5-1064C64D1A6D @default.
- Q63811530 P6153 Q63811530-DDA94418-9D91-41B6-94FF-B040738DA9FC @default.
- Q63811530 P6153 Q63811530-DE79A79A-4A39-4A58-9448-2812B1C4B5F6 @default.
- Q63811530 P8363 Q63811530-068691D1-60E8-4624-9218-A0BED103C024 @default.
- Q63811530 P1050 Q585285 @default.
- Q63811530 P1132 "+188" @default.
- Q63811530 P1476 "The Combination of Low-dose Rituximab and All-trans Retinoic Acid as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia: a Multicenter, Randomized, Open-label Trial" @default.
- Q63811530 P2899 "+18" @default.
- Q63811530 P3098 "NCT03304288" @default.
- Q63811530 P31 Q30612 @default.
- Q63811530 P4844 Q29417 @default.
- Q63811530 P4844 Q412323 @default.
- Q63811530 P580 "2017-01-01T00:00:00Z" @default.
- Q63811530 P582 "2017-12-31T00:00:00Z" @default.
- Q63811530 P6099 Q42824440 @default.
- Q63811530 P6153 Q30260307 @default.
- Q63811530 P6153 Q4881199 @default.
- Q63811530 P6153 Q936190 @default.
- Q63811530 P8363 Q78089383 @default.